AxoGen develops technologies for peripheral nerve regeneration and repair worldwide. Its products include Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector, and Axoguard HA+ Nerve Protector. These products are used to bridge severed nerves, protect damaged nerves, and prevent soft tissue attachments. The company also offers Axoguard Nerve Cap, which protects nerve ends and separates them from the surrounding environment. Additionally, AxoGen provides AxoTouch two-point discriminator for measuring skin innervation density. Products are supplied to hospitals, surgery centers, military hospitals, and various surgeons.
Indicator | Value |
---|---|
PER | 100.0 |
EV/EBITDA | 166.6 |
Price/Free Cash Flow' | 62169.5 |
ROIC | 2.6% |
Net Debt/EBITDA | 9.5 |